In 2023, the average length of stay for patients with deforming dorsopathies and spondylopathies in Canadian hospitals was 8.9 days. Based on forecasted data, this average remains stable at 8.9 days from 2024 to 2026, with a slight decrease to 8.8 days in 2027 and 2028. The year-on-year percentage variations from 2024 to 2028 reflect minimal change, indicating stability in hospital management and treatment protocols over this period. The compound annual growth rate (CAGR) over these years is negligible, signifying a steady pattern with no significant increase or decrease in the average length of stay.
Future trends to watch for include advancements in treatment techniques and healthcare technology that may further reduce the average length of stay. Additionally, policy changes and hospital efficiency improvements could influence these metrics, potentially leading to shorter hospitalizations and altered resource allocation.
